Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: May 12, 2021
Date Accepted: Sep 16, 2021

The final, peer-reviewed published version of this preprint can be found here:

The Communicating Narrative Concerns Entered by Registered Nurses (CONCERN) Clinical Decision Support Early Warning System: Protocol for a Cluster Randomized Pragmatic Clinical Trial

Rossetti SC, Dykes PC, Knaplund C, Kang MJ, Schnock K, Garcia J, Fu LH, Chang F, Thai T, Fred M, Korach TZ, Zhou L, Klann J, Albers D, Schwartz J, Lowenthal G, Jia H, Liu F, Cato K

The Communicating Narrative Concerns Entered by Registered Nurses (CONCERN) Clinical Decision Support Early Warning System: Protocol for a Cluster Randomized Pragmatic Clinical Trial

JMIR Res Protoc 2021;10(12):e30238

DOI: 10.2196/30238

PMID: 34889766

PMCID: 8709914

The CONCERN Clinical Decision Support Early Warning System: A Cluster Randomized Pragmatic Clinical Trial

  • Sarah Collins Rossetti; 
  • Patricia C. Dykes; 
  • Chris Knaplund; 
  • Min-Jeoung Kang; 
  • Kumiko Schnock; 
  • Jose Garcia; 
  • Li-Heng Fu; 
  • Frank Chang; 
  • Tien Thai; 
  • Matthew Fred; 
  • Tom Z. Korach; 
  • Li Zhou; 
  • Jeff Klann; 
  • Dave Albers; 
  • Jessica Schwartz; 
  • Graham Lowenthal; 
  • Haomiao Jia; 
  • Fang Liu; 
  • Kenrick Cato

ABSTRACT

Background:

The overarching goal of the COmmunicating Narrative Concerns Entered by RNs (CONCERN) study is to implement and evaluate an early warning score system which provides clinical decision support (CDS) in electronic health record systems. The CONCERN CDS uses nursing documentation patterns as indicators of nurses’ increased surveillance to predict when patients are at risk of clinical deterioration.

Objective:

The objective of this cluster randomized pragmatic clinical trial is to evaluate the effectiveness and usability of the CONCERN CDS system at two different study sites. The specific aim is to decrease hospitalized patients’ negative health outcomes (in-hospital mortality, length of stay, cardiac arrest, unanticipated ICU transfers, and 30-day hospital readmission rates).

Methods:

A multiple time-series intervention consisting of three phases will be performed through a one-year period during the cluster randomized pragmatic clinical trial. It deals with a series of processes from system release to evaluation. The system release includes CONCERN CDS implementation and user training. Then, a mixed methods approach will be conducted with end-users to assess the system and clinician perspectives.

Results:

Study results are expected in 2022.

Conclusions:

The CONCERN CDS will increase team-based situational awareness and shared understanding of patients predicted to be at risk for clinical deterioration in need of intervention to prevent mortality and associated harm. Clinical Trial: ClinicalTrials.gov | Identifier: NCT03911687


 Citation

Please cite as:

Rossetti SC, Dykes PC, Knaplund C, Kang MJ, Schnock K, Garcia J, Fu LH, Chang F, Thai T, Fred M, Korach TZ, Zhou L, Klann J, Albers D, Schwartz J, Lowenthal G, Jia H, Liu F, Cato K

The Communicating Narrative Concerns Entered by Registered Nurses (CONCERN) Clinical Decision Support Early Warning System: Protocol for a Cluster Randomized Pragmatic Clinical Trial

JMIR Res Protoc 2021;10(12):e30238

DOI: 10.2196/30238

PMID: 34889766

PMCID: 8709914

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.